J and J Snack Foods Newswire
Comprehensive Real-Time News Feed for J and J Snack Foods.
Results 1 - 20 of 1,359 in J and J Snack Foods
-
News Summary: J&J predicts surge of new medicines
BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones. Comment?
-
J&J Embraces "Special K" for Depression - Why Not Medical Marijuana?
w/Photo
Current antidepressants take weeks or months to have an effect, and then only in 30% of patients, notes Matthew Herper, Forbes, in a recent post . Comment?
-
J&J plots course to 2017
w/Photo
Johnson & Johnson, the world's biggest maker of health care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017, including a modified version of a decades-old anesthetic that has been misused as a date-rape drug. Comment?
-
News Summary: J&J predicts surge of new medicines Big Plans: Johnson...
BIG IMPACT: Two experimental medicines could transform current treatments. One is an antidepressant that appears to work in just a day, instead of taking weeks. Comment?
-
Big plans : Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones. Comment?
-
P&G Ceo Bob McDonald Steps Down After Pressure From Bill Ackman, Activist Investor
w/Photo
Bob McDonald, the 59-year-old CEO of Procter & Gamble and a 33-year veteran of the company, has stepped down suddenly. Comment?
-
J&J plans slew of regulatory filings through 2017
Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday. Comment?
-
J&J expects 10-plus new drug applications by 2017
Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during a review of the health care giant's medicine business. Comment?
-
J&J expects 10-plus drug applications by 2017
Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during a review of the health care giant's medicine business. Comment?
-
News Summary: J&J predicts surge of new medicines
BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones. Comment?
-
J&J forecasts 10 new drug applications by 2017
Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017. Comment?
-
J&J hopes for 10 new treatments by 2017
w/Photo
Health-care giant Johnson & Johnson plans to seek approval for 10 new treatments to combat cancer, Hepatitis C, schizophrenia and influenza over the next four years, the company said Thursday. Comment?
-
More Danger Signs for the Market
Reuben is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. Comment?
-
J&J to Submit More Than 10 New Drug Applications by 2017
Johnson & Johnson said its pharmaceutical unit plans to submit more than 10 new-product applications by 2017, as the health-care heavyweight hopes to build on the division's turnaround in recent years. Comment?
-
How Dividends Change the Game for Cisco Shareholders
The wealth-building power of compound interest will never cease to amaze me. It's a story of patience and attention to detail, where small, short-term differences add up to massive divergence over decades. Comment?
-
Johnson & Johnson Is Reinventing The Party Drug Ketamine To Treat Depression
Until joining the company a few years ago, J&J neuroscience R&D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health . Comment?
-
J&J to Submit Over 10 New Drug Applications by 2017
Johnson & Johnson said its pharmaceutical unit plans to submit more than 10 new product applications by 2017, as the health-care heavyweight hopes to build on the division's turnaround in recent years. Comment?
-
J&J Sees 10 Potential Drugs Submitted for Approval by 2017
Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017. Comment?
-
J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer
I'm at Johnson & Johnson 's Pharmaceutical Business Review today. Most of the day is dedicated to geeky drug R&D stuff, but Joaquin Duato started of the morning with a run-down of how J&J's pharmaceutical division is doing in terms of cold, hard sales. Comment?
-
UPDATE 1-J&J plans filing on more than 10 new drugs by 2017
Johnson & Johnson said on Thursday it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and polio. Comment?
J and J Snack Foods Forum
Most Popular
- Irishman charged with 1982 IRA Hyde Park bombing - 153 comments
- Judge rules against 'America's toughest sheriff' in racial profiling lawsuit - 103 comments
- Suspected Muslim terrorists hack man to death - 102 comments
- Richie Sambora on Bon Jovi Split: 'Enough With the Trash Talking' - 87 comments
- Pressing Poland on restitution poses dilemma for US, Jewish groups - 91 comments
- Anti-Gay Event Offers Free Chick-fil-A - 104 comments
- Obama Narrows Scope of Counterterrorism Fight - 57 comments
- Rage in London after Beheading - 29 comments
- Egypt: 3 women killed in 'honor' crime - 42 comments
- Anti-Gay Groups Furious After Boy Scout Vote - 29 comments
Copyright ©2013 Topix LLC
